{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:04:01Z","timestamp":1791295441313,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040456","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T21:01:55Z","timestamp":1341608515000},"page":"e40456","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama"],"prefix":"10.1371","volume":"7","author":[{"given":"Bing-Shao","family":"Chia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedora","family":"Lanzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Rifat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubrey","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sailer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Torres-Chavolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvaja","family":"Narayanaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Einarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Pascale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Ioerger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Sacchettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"ref1","first-page":"WHO\/HTM\/TB\/2011.16","article-title":"WHO report 2011: global tuberculosis control.","year":"2011"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1164\/ajrccm.163.5.2007122","article-title":"The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps.","volume":"163","author":"RJ O'Brien","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1471-2180-6-90","article-title":"Molecular characterisation of Mycobacterium tuberculosis isolates in the First National Survey of Anti-tuberculosis Drug Resistance from Venezuela.","volume":"6","author":"L Aristimuno","year":"2006","journal-title":"BMC Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2180-9-39","article-title":"Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.","volume":"9","author":"ER Dalla Costa","year":"2009","journal-title":"BMC Microbiol"},{"key":"ref5","first-page":"87","article-title":"Prevalence of katG Ser315 substitution and rpoB mutations in isoniazid-resistant Mycobacterium tuberculosis isolates from Brazil.","volume":"9","author":"CC Hofling","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref6","article-title":"US Census Bureau. The hispanic population: 2010. C2010BR-04.","year":"2012"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1164\/rccm.200608-1178OC","article-title":"Tuberculosis among foreign-born persons in the United States: achieving tuberculosis elimination.","volume":"175","author":"KP Cain","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.pmed.1000002","article-title":"Tuberculosis drug resistance mutation database.","volume":"6","author":"A Sandgren","year":"2009","journal-title":"PLoS Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.","volume":"358","author":"Y Zhang","year":"1992","journal-title":"Nature"},{"key":"ref10","first-page":"271","article-title":"Mechanisms of Action and Resistance of Antimycobacterial Agents.","author":"PC Karakousis","year":"2009"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2005.06.007","article-title":"Simultaneous detection of isoniazid, rifampin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay.","volume":"53","author":"Z Yang","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/jac\/dkm086","article-title":"Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.","volume":"59","author":"MV Afanas'ev","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1128\/JCM.00330-06","article-title":"Mutations prevalent among rifampin- and isoniazid-resistant Mycobacterium tuberculosis isolates from a hospital in Vietnam.","volume":"44","author":"M Caws","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/AAC.01124-07","article-title":"Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations.","volume":"52","author":"M Gegia","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1128\/AAC.46.5.1417-1424.2002","article-title":"High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.","volume":"46","author":"I Mokrousov","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.mimet.2005.03.002","article-title":"Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea.","volume":"63","author":"YK Park","year":"2005","journal-title":"J Microbiol Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/JCM.40.3.1091-1094.2002","article-title":"rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries.","volume":"40","author":"L Qian","year":"2002","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1099\/jmm.0.05343-0","article-title":"Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico.","volume":"53","author":"SV Ramaswamy","year":"2004","journal-title":"J Med Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/JCM.39.2.636-641.2001","article-title":"Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community.","volume":"39","author":"A Van Rie","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1128\/JCM.41.5.2209-2212.2003","article-title":"Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China.","volume":"41","author":"J Yue","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/JCM.32.4.1095-1098.1994","article-title":"Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.","volume":"32","author":"V Kapur","year":"1994","journal-title":"J Clin Microbiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1128\/JCM.40.12.4435-4438.2002","article-title":"Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from Turkey by DNA sequencing and line probe assay.","volume":"40","author":"C Cavusoglu","year":"2002","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance.","volume":"363","author":"CC Boehme","year":"2010","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/AAC.47.1.188-195.2003","article-title":"Exploring the structure and function of the mycobacterial KatG protein using trans-dominant mutants.","volume":"47","author":"JA DeVito","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1128\/AAC.47.4.1241-1250.2003","article-title":"Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis.","volume":"47","author":"SV Ramaswamy","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1371\/journal.ppat.0020061","article-title":"Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis.","volume":"2","author":"S Gagneux","year":"2006","journal-title":"PLoS Pathog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/JB.181.4.1343-1347.1999","article-title":"Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.","volume":"181","author":"M Payton","year":"1999","journal-title":"J Bacteriol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-2836(02)00141-9","article-title":"The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis\u2013an enzyme which inactivates the anti-tubercular drug, isoniazid.","volume":"318","author":"J Sandy","year":"2002","journal-title":"J Mol Biol"},{"key":"ref29","article-title":"Pan American Health Organization. Manual for the bacteriological diagnosis of tuberculosis (Spanish version).","year":"2012"},{"key":"ref30","article-title":"Technical proceedings for the bacteriological diagnostic of Tuberculosis."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e7778","DOI":"10.1371\/journal.pone.0007778","article-title":"Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa.","volume":"4","author":"TR Ioerger","year":"2009","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1054\/tuld.1998.0002","article-title":"Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.","volume":"79","author":"S Ramaswamy","year":"1998","journal-title":"Tuber Lung Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1286-4579(00)00359-2","article-title":"The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.","volume":"2","year":"2000","journal-title":"Microbes Infect"},{"key":"ref34","first-page":"1306","article-title":"Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis.","volume":"12","author":"DQ Tho","year":"2008","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T10:54:57Z","timestamp":1594378497000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040456"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040456","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,6]]}}}